Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: Adebrelimab Combined With AG Regimen in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update exploring adebrelimab in combination with the AG regimen (nab-paclitaxel + gemcitabine) for unresectable local…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Perioperative Immune Function and Clinical Complications in Pancreaduodenectomy
The trial evaluating perioperative immune function and postoperative complications in patients undergoing pancreaticoduodenectomy for pancre…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer [Phase 3]
A Phase 3 multi-center trial evaluating multiple regimens for metastatic pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies
Completed clinical trial update evaluating the use of liquid biopsies to reduce cancer death risk during viral pandemics. The provided snipp…
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer (SHAPER) [Phase 1]
Phase 1 clinical trial SHAPER investigates losartan with hypofractionated radiotherapy after chemotherapy for Borderline Resectable or Local…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: Study of XB002 in Subjects With Solid Tumors (JEWEL-101) [Phase 1]
JEWEL-101 is a Phase 1 trial of XB002 in patients with solid tumors, covering multiple indications. The study has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: The RIOT Trial: Re-Defining Frailty and Improving Outcomes With Prehabilitation for Pancreatic, Liver, or Gastric Cancer [NA]
The RIOT trial evaluating prehabilitation to reduce frailty and improve outcomes in pancreatic, liver, and gastric cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors [Phase 2]
A Phase 2 study of seribantumab in adults with NRG1 gene fusion-positive advanced solid tumors has been terminated, with results posted in A…
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: Maintenance Chemotherapy With S-1 vs. Observation After Adjuvant Therapy for Resected Pancreatic Cancer With High Risk of Recurrence/Metastasis [Phase 4]
A Phase 4 clinical trial is evaluating maintenance S-1 chemotherapy versus observation after adjuvant therapy in patients with resected panc…
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: RNA Precision Oncology in Advanced Pancreatic Cancer [NA]
A clinical trial investigating RNA precision oncology in advanced pancreatic cancer has terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies [Phase 1, Phase 2]
Phase 1/2 open-label study evaluating Alomfilimab (KY1044) alone and with atezolizumab in multiple advanced cancers. The trial was terminate…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Prediction of Surgical Resectability After FOLFIRINOX Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: the Role of Diffusion Weighted Magnetic Resonance Imaging, Radiomics and Liquid Biopsy (PeRFormanCe Trial) [NA]
The PeRFormanCe trial is exploring diffusion-weighted MRI, radiomics, and liquid biopsy to predict surgical resectability after FOLFIRINOX i…
-
CLINICAL_TRIALS research · 2025-04-01Clinical Trial Update: Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer
Stanford University is running a clinical trial to build a bio-repository of high-risk cohorts for the early detection of pancreatic cancer.…
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: INTER-Regional COHORTE of Long Term Pancreatic Cancer Survivors
The INTER-Regional COHORTE study of long-term pancreatic cancer survivors has completed.
-
CLINICAL_TRIALS research · 2025-03-27Clinical Trial Update: Music Therapy in Patients Undergoing Pancreatic Surgery (MUSIC PUPS) [NA]
The MUSIC PUPS trial evaluates music therapy for postoperative pain management in patients undergoing pancreatic surgery (Whipple procedure …
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: BPM31510 Administered Intravenously With Gemcitabine in Advanced Pancreatic Cancer Patients [Phase 2]
Phase 2 trial evaluating BPM31510 in combination with gemcitabine for advanced pancreatic cancer has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-03-25Clinical Trial Update: Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography. [Phase 2]
A Phase 2 trial evaluating a ketamine-midazolam sedative regimen for endoscopic retrograde cholangiopancreatography has completed, involving…
-
CLINICAL_TRIALS trial_result · 2025-03-25Clinical Trial Update: Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors [Phase 2]
Phase 2 study of tusamitamab ravtansine as monotherapy and in combination for CEACAM5-positive advanced solid tumors (metastatic breast canc…
-
CLINICAL_TRIALS trial_result · 2025-03-25Clinical Trial Update: A Study to Find a Safe and Effective Dose of BI 905711 in Patients With Advanced Gastrointestinal Cancer [Phase 1]
Phase 1 study to determine a safe and potentially effective dose of BI-905711 in patients with advanced gastrointestinal cancers, including …
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial is evaluating amplitude-modulated radiofrequency electromagnetic fields for metastatic pancreatic cancer, and the s…
-
CLINICAL_TRIALS trial_result · 2025-03-25Clinical Trial Update: A Trial of Cobicistat and Gemcitabine and Nab-Paclitaxel in Patients with Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma [Phase 1]
Phase 1 trial evaluating cobicistat in combination with gemcitabine and nab-paclitaxel in advanced or metastatic pancreatic ductal adenocarc…
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Clinical Study of Carbon Ion Radiotherapy for Pancreatic Cancer. [NA]
This clinical trial is evaluating carbon ion radiotherapy for pancreatic cancer, including metastatic and non-resectable cases, and is curre…
-
CLINICAL_TRIALS other · 2025-03-25Clinical Trial Update: Monitoring of patIents With Microdialysis Following Pancreaticoduodenectomy [NA]
Trial update from Oslo University Hospital on monitoring patients with microdialysis after pancreaticoduodenectomy. The study is currently a…
-
CLINICAL_TRIALS research · 2025-03-24Clinical Trial Update: Clinical Study of Tumor Treating Fields Combined with Gemcitabine and Albumin-bound Paclitaxel in the First-line Treatment of Locally Advanced Pancreatic Cancer [Phase 3]
Ongoing Phase 3 clinical trial evaluating the combination of Tumor Treating Fields with gemcitabine and nab-paclitaxel as first-line therapy…
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) [Phase 1]
A Phase 1 clinical trial evaluating the safety and efficacy of NRT6008 in patients with unresectable locally advanced pancreatic cancer, spo…